Company Revive Therapeutics Ltd Toronto S.E.
Equities
RVV
CA7615161030
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CAD | -.--% |
|
+6.67% | -11.11% |
Business description: Revive Therapeutics Ltd
Sales by Activity: Revive Therapeutics Ltd
Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 |
---|
Geographical breakdown of sales: Revive Therapeutics Ltd
Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 |
---|
Managers: Revive Therapeutics Ltd
Director | Title | Age | Since |
---|---|---|---|
Michael Frank
CEO | Chief Executive Officer | - | 19-12-17 |
Carmelo Marrelli
DFI | Director of Finance/CFO | 53 | - |
Members of the board: Revive Therapeutics Ltd
Manager | Title | Age | Since |
---|---|---|---|
William Jackson
BRD | Director/Board Member | - | 13-12-31 |
Michael Frank
CEO | Chief Executive Officer | - | 19-12-17 |
Joshua Herman
BRD | Director/Board Member | - | 19-12-17 |
Director/Board Member | 50 | 19-12-17 | |
Andrew Lindzon
BRD | Director/Board Member | 63 | 19-12-17 |
Company details: Revive Therapeutics Ltd
Revive Therapeutics Ltd.
The Canadian Venture Building 82 Richmond Street East
M5C 1P1, Toronto
+888-901-0036
http://www.revivethera.com![address Revive Therapeutics Ltd(RVV)](https://cdn.zonebourse.com/static/address/18313352.png)
Bio Therapeutic Drugs
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
+0.45% | -3.22% | +36.94% | +75.48% | 123B | ||
+0.84% | -0.80% | +36.73% | +151.76% | 123B | ||
-0.73% | +0.39% | +0.49% | +77.59% | 32.38B | ||
-1.35% | +11.51% | -15.84% | -71.57% | 23.6B | ||
+6.80% | +11.93% | +0.91% | -40.01% | 22.43B | ||
-0.15% | -3.08% | -30.21% | -35.00% | 16.95B | ||
-1.18% | +89.17% | +1,292.64% | +249.23% | 16.45B | ||
+3.35% | -2.18% | -50.27% | -72.63% | 15.37B | ||
-2.31% | +4.03% | +116.62% | +334.06% | 14.05B | ||
Average | +0.52% | +12.39% | +154.22% | +74.32% | 43B | |
Weighted average by Cap. | +0.32% | +4.20% | +78.37% | +90.19% |
- Stock Market
- Equities
- RVV Stock
- RVV Stock
- Company Revive Therapeutics Ltd